24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy
Latest Information Update: 16 Dec 2022
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- Sponsors AbbVie
- 26 Jan 2022 Status changed from active, no longer recruiting to completed.
- 20 May 2021 Planned End Date changed from 4 Jun 2021 to 5 Jan 2022.
- 20 May 2021 Planned primary completion date changed from 4 Jun 2021 to 7 Dec 2021.